The Forteo Patient Registry linkage to multiple state cancer registries: study design and results from the first 8 years

SUMMARY: The Forteo Patient Registry (FPR) aims to estimate the incidence of osteosarcoma in US patients treated with teriparatide. Enrollment began in 2009 and will continue through 2019, with linkage planned through 2024. To date, no incident cases of osteosarcoma have been identified among patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilsenan, A., Harding, A., Kellier-Steele, N., Harris, D., Midkiff, K., Andrews, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154045/
https://www.ncbi.nlm.nih.gov/pubmed/29978254
http://dx.doi.org/10.1007/s00198-018-4604-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154045/
https://www.ncbi.nlm.nih.gov/pubmed/29978254
http://dx.doi.org/10.1007/s00198-018-4604-8

Ejemplares similares